Condition (MeSH)
Hypokalemia
ClinicalTrials.gov lists 38 trials for Hypokalemia or a narrower condition beneath it. AstraZeneca has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
38 of the 38 trials are tagged with Hypokalemia itself; the rest are tagged with a narrower condition beneath it.
When did Hypokalemia trials start? (20)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2024 | 1 |
| 2023 | 2 |
| 2022 | 4 |
| 2021 | 2 |
| 2020 | 1 |
| 2019 | 1 |
| 2017 | 3 |
| 2016 | 2 |
Showing 10 of 20 earlier years.
No forecast is made for this condition: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hypokalemia trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 2 |
| Phase 2 | 1 |
| Phase 4 | 13 |
| Not applicable | 13 |
| Observational | 9 |
How many Hypokalemia trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 3 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 2 |
| Completed | 23 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hypokalemia trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| AstraZeneca | 1 |
Which drugs are being tested for Hypokalemia? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Osilodrostat | 2 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| HCTZ-hydrochlorothiazide | 2 |
| Furosemide-IR | 1 |
| IV-PCA | 1 |
| low-dose dopamine + low-dose furosemide | 1 |
| High-dose furosemide | 1 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Hypokalemia? (124)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| AI-enabled electrocardiogram alert for potassium imbalance treatment: a pragmatic randomized controlled trial. | Nature communications | 2026 | Yes |
| Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysis. | European heart journal. Cardiovascular pharmacotherapy | 2025 | Yes |
| Hypokalemia During Decongestion With Loop Diuretics and Hydrochlorothiazide, a Post Hoc Analysis of the CLOROTIC Trial. | Circulation. Heart failure | 2025 | Yes |
| Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias. | The New England journal of medicine | 2025 | Yes |
| Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. | European heart journal | 2023 | Yes |
Showing 5 of 124 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.